S. Parvathy

671 citations
11 papers · 554 indexed · h-index 9
Topics
Alzheimer's disease research and treatments (10 papers)Cholinesterase and Neurodegenerative Diseases (4 papers)Protein Hydrolysis and Bioactive Peptides (3 papers)

In The Last Decade

S. Parvathy

10 papers receiving 540 citations

Peers

S. Parvathy
Comparison fields: 5 of 73
  • Physiology 387
  • Molecular Biology 249
  • Pharmacology 112
  • Cell Biology 80
  • Cellular and Molecular Neuroscience 77
Replace Pascal Merchiers with:
Pascal Merchiers Belgium
Sebastian Hogl Germany
Lauren Herl United States
Wakako Yamao‐Harigaya Japan
Anja Schroeder Germany
Elvira Lopez‐Perez France
Mirsada Čaušević United Kingdom
Karl H. Weisgraber United States
Chinatsu Hattori Japan
R Bhasin United States
S. Parvathy relative to Pascal Merchiers Belgium Pascal Merchiers's profile →
Citations per field
00.5×1.5×
Pascal Merchiers · 1×
Citations per year

Countries citing papers authored by S. Parvathy

Since Specialization
Citations

This map shows the geographic impact of S. Parvathy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Parvathy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Parvathy more than expected).

Fields of papers citing papers by S. Parvathy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Parvathy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Parvathy. The network helps show where S. Parvathy may publish in the future.

Co-authorship network of co-authors of S. Parvathy

This figure shows the co-authorship network connecting the top 25 collaborators of S. Parvathy. A scholar is included among the top collaborators of S. Parvathy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Parvathy. S. Parvathy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 38
2 22
3 56
4
MOLECULAR GENETICS OF ALZHEIMER DISEASE
0
5 79
6 154
7 9
8 43
9 7
10 102
11 44

About S. Parvathy

S. Parvathy is a scholar working on Physiology, Pharmacology and Cancer Research, having authored 11 papers that have together received 554 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (10 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Protein Hydrolysis and Bioactive Peptides (3 papers). The work is most often cited by research in Physiology (387 citations), Neurology (66 citations) and Pharmacology (112 citations). S. Parvathy has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Eric Karran, Nigel M. Hooper, Anthony J. Turner, Ishrut Hussain, Joseph D. Buxbaum, Heather Ryan, Greer M. Murphy, Joseph Yat‐Sun Chan, Kenneth L. Davis and Peter Davies. Their work appears in journals such as Biochemistry, Biochemical Journal and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026